Insider Trading & Ownership - Aquestive Therapeutics Inc. (AQST)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Aquestive Therapeutics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2024-03-15
Sale		2024-03-19
2:30 pm		Aquestive Therapeutics Inc.AQSTSchobel Alexander Mark
Chief Innovation/Tech Officer		50,000$6$300,000984,476
(Direct)		View
2024-03-08
Sale		2024-03-12
1:45 pm		Aquestive Therapeutics Inc.AQSTSchobel Alexander Mark
Chief Innovation/Tech Officer		25,000$5.1874$129,6851,034,476
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-03-09
Tax Withholding(A)		2024-10-02
2:16 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTSchobel Alexander Mark
Chief Innovation/Tech Officer		9,645$4.88980,726
(Direct)		View
2024-03-09
Tax Withholding(A)		2024-10-02
2:15 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTWargacki Stephen
Chief Science Officer		19,505$4.88261,414
(Direct)		View
2024-03-09
Tax Withholding(A)		2024-10-02
2:15 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTBarber Daniel
President and CEO		56,824$4.88826,478
(Direct)		View
2024-03-09
Tax Withholding(A)		2024-10-02
2:14 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTJung Cassie
SVP, Operations		14,120$4.88235,110
(Direct)		View
2024-08-09
Tax Withholding		2024-08-12
2:45 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTKraus Carl N
Chief Medical Officer		10,819$3.43251,681
(Direct)		View
2024-06-20
Option Award		2024-06-21
1:51 pm		2025-06-20
2034-06-20		Aquestive Therapeutics Inc.AQSTMORRIS TIMOTHY E
Director		38,000$038,000
(Direct)		View
2024-06-20
Option Award		2024-06-21
1:51 pm		2025-06-20
2034-06-20		Aquestive Therapeutics Inc.AQSTTaglietti Marco
Director		38,000$038,000
(Direct)		View
2024-06-20
Option Award		2024-06-21
1:51 pm		2025-06-20
2034-06-20		Aquestive Therapeutics Inc.AQSTBROWN GREGORY B
Director		38,000$0113,085
(Direct)		View
2024-06-20
Option Award		2024-06-21
1:50 pm		2025-06-20
2034-06-20		Aquestive Therapeutics Inc.AQSTKrop Julie
Director		38,000$038,000
(Direct)		View
2024-06-20
Option Award		2024-06-21
1:50 pm		2025-06-20
2034-06-20		Aquestive Therapeutics Inc.AQSTCochran John
Director		38,000$0137,486
(Direct)		View
2024-06-20
Option Award		2024-06-21
1:50 pm		2025-06-20
2034-06-20		Aquestive Therapeutics Inc.AQSTCOSTA SANTO J
Director		38,000$055,327
(Direct)		View

Ownership(A)		2024-06-12
5:14 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTKorczynski Sherry
SVP Sales and Marketing		0$050,000
(Direct)		View
2024-06-07
Option Award		2024-06-11
12:36 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTKorczynski Sherry
SVP Sales and Marketing		25,000$025,000
(Direct)		View

Ownership		2024-06-11
12:35 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTKorczynski Sherry
SVP Sales and Marketing		0$00
(Direct)		View
2024-05-10
Option Award		2024-05-13
1:40 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTWargacki Stephen
Chief Science Officer		10,000$0267,963
(Direct)		View
2024-05-10
Option Award		2024-05-13
1:40 pm		N/A
2034-05-10		Aquestive Therapeutics Inc.AQSTJenkins Abigail L.
Director		57,000$057,000
(Direct)		View

Ownership		2024-04-26
09:20 am		N/A
N/A		Aquestive Therapeutics Inc.AQSTJenkins Abigail L.
Director		0$00
(Direct)		View
2024-03-09
Tax Withholding		2024-03-12
1:47 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTBarber Daniel
President and CEO		37,938$4.88845,364
(Direct)		View
2024-03-09
Tax Withholding		2024-03-12
1:47 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTBoyd Peter E.
See Remark		8,370$4.88237,628
(Direct)		View
2024-03-09
Tax Withholding		2024-03-12
1:47 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTBRAENDER LORI J
SVP, General Counsel		10,530$4.88313,231
(Direct)		View
2024-03-09
Tax Withholding		2024-03-12
1:47 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTTOTH A ERNEST JR
SVP, Chief Financial Officer		11,705$4.88248,295
(Direct)		View
2024-03-09
Tax Withholding		2024-03-12
1:46 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development		12,956$4.88257,963
(Direct)		View
2024-03-09
Tax Withholding		2024-03-12
1:46 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTJung Cassie
SVP, Operations		9,432$4.88239,798
(Direct)		View
2024-03-09
Tax Withholding		2024-03-12
1:45 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTSchobel Alexander Mark
Chief Innovation/Tech Officer		5,895$4.881,034,476
(Direct)		View
2024-03-07
Option Award		2024-03-11
10:36 am		N/A
2034-03-07		Aquestive Therapeutics Inc.AQSTBRAENDER LORI J
SVP, General Counsel		202,500$0391,261
(Direct)		View
2024-03-07
Option Award		2024-03-11
10:36 am		N/A
2034-03-07		Aquestive Therapeutics Inc.AQSTTOTH A ERNEST JR
SVP, Chief Financial Officer		180,000$0320,000
(Direct)		View
2024-03-07
Option Award		2024-03-11
10:36 am		N/A
2034-03-07		Aquestive Therapeutics Inc.AQSTSchobel Alexander Mark
Chief Innovation/Tech Officer		123,750$01,106,621
(Direct)		View
2024-03-07
Option Award		2024-03-11
10:35 am		N/A
2034-03-07		Aquestive Therapeutics Inc.AQSTKraus Carl N
Chief Medical Officer		168,750$0318,750
(Direct)		View
2024-03-07
Option Award		2024-03-11
10:35 am		N/A
2034-03-07		Aquestive Therapeutics Inc.AQSTBarber Daniel
President and CEO		606,500$01,247,202
(Direct)		View
2024-03-07
Option Award		2024-03-11
10:35 am		N/A
2024-03-07		Aquestive Therapeutics Inc.AQSTJung Cassie
SVP, Operations		151,875$0299,855
(Direct)		View
2023-03-10
Tax Withholding		2024-03-11
10:35 am		N/A
N/A		Aquestive Therapeutics Inc.AQSTJung Cassie
SVP, Operations		1,365$0299,855
(Direct)		View
2024-03-07
Option Award		2024-03-11
10:35 am		N/A
2034-03-07		Aquestive Therapeutics Inc.AQSTBoyd Peter E.
See Remark		129,375$0289,123
(Direct)		View
2023-03-10
Tax Withholding		2024-03-11
10:34 am		N/A
N/A		Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development		1,981$0.7937327,169
(Direct)		View
2024-03-07
Option Award		2024-03-11
10:34 am		N/A
2034-03-07		Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development		168,750$0327,169
(Direct)		View
2023-08-09
Option Award		2023-08-09
4:30 pm		N/A
2026-05-05		Aquestive Therapeutics Inc.AQSTBRAENDER LORI J
SVP, General Counsel		75,000$075,000
(Direct)		View
2023-08-09
Option Award		2023-08-09
4:30 pm		N/A
2026-05-05		Aquestive Therapeutics Inc.AQSTBarber Daniel
President and CEO		223,500$0223,500
(Direct)		View
2023-08-09
Option Award		2023-08-09
4:30 pm		N/A
2026-05-05		Aquestive Therapeutics Inc.AQSTBoyd Peter E.
See Remark		50,000$050,000
(Direct)		View
2023-08-09
Option Award		2023-08-09
4:30 pm		N/A
2026-05-05		Aquestive Therapeutics Inc.AQSTMarshall Ken W.
SVP, Chief Commercial Officer		75,000$075,000
(Direct)		View
2023-08-09
Option Award		2023-08-09
4:30 pm		N/A
N/A		Aquestive Therapeutics Inc.AQSTKraus Carl N
Chief Medical Officer		150,000$0150,000
(Direct)		View
2023-08-09
Option Award		2023-08-09
4:30 pm		N/A
2026-05-05		Aquestive Therapeutics Inc.AQSTWargacki Stephen
SVP, Research & Development		67,500$067,500
(Direct)		View
2023-08-09
Option Award		2023-08-09
4:30 pm		N/A
2026-05-05		Aquestive Therapeutics Inc.AQSTTOTH A ERNEST JR
SVP, Chief Financial Officer		70,000$070,000
(Direct)		View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, Next